Serum response factor is a MADS box transcription factor which binds to consensus sequences CC(A/T) 6 GG found in the promoter region of several serum-inducible and muscle-specific genes. In skeletal myocytes SRF has been shown to hetrodimerize with the myogenic basic helixloop-helix family of factors related to MyoD, for control of muscle gene regulation. Here we report that SRF binds to another myogenic factor, TEF-1 that has been implicated in the regulation of a variety of cardiac muscle genes. By using different biochemical assays such as affinity precipitation of protein, GST-pull down assay and co-immunoprecipitation of proteins, we showed that SRF binds to TEF-1 both in vitro and in vivo assay conditions. A strong interaction of SRF with TEF-1 was seen even when one protein was denatured and immobilized on nitrocellulose membrane, indicating a direct and stable interaction between SRF and TEF-1 which occurs without a cofactor. This 
INTRODUCTION
Serum response factor (SRF) belongs to a super family of transcription factors which contain a highly conserved DNA-binding and dimerization domain termed as MADS-box, because of its homology among yeast (MCM1, Agamous) plant (Deficiens) and vertebrate (SRF) proteins (1, 2) .
MADS proteins play a wide range of functions from development in plants to muscle cell differentiation and growth response in mammalian cells (reviewed in ref 2) . SRF is a 67kDa molecular weight phosphoprotein that was first identified as a major regulatory protein controlling the serum-activated expression of the c-fos gene. SRF regulates gene transcription through binding to a consensus DNA sequence, the serum response element (SRE), CC(A/T) 6 GG also known as CArG box (2) (3) (4) . Functional SREs are found in the promoter region of many immediate early genes involved in the mitogenic response of proliferative cells (2) (3) (4) . Paradoxically, SREs are also found in the promoters of several muscle genes expressed in post-replicative myocytes, where they are involved in controlling the gene tissue-specificity as well as their response to hypertrophic growth stimuli (5) (6) (7) (8) . SREs between muscle and non-muscle gene promoters can be interchanged without loss of their function (9) , thus suggesting that in addition of SRF binding to SRE in both types of promoters, its activity is very much governed by other cell-type and promoter specific factors interacting with SRF. 4 modulated from proliferative myoblast to control muscle gene expression in differentiated myocytes (15) . However, there are many other muscle genes which have a functional SRE, but do not require myogenic basic helix-loop-helix family of factors for their tissue-specific regulation. For example, genes expressed in cardiac myocytes such as cardiac a-actin (7), skeletal a-actin (17) , MLC-2 (18), a-MHC (19) , ANF (20) , MCK (21) as well as cardiac troponin T (22, 23) all possess SREs that are critical for their activation in cardiac muscle cell context, but are independent of MyoD regulatory mechanisms. Therefore, it is likely that the SRE of these promoters could be interacting with other muscle-specific regulatory elements for gene trans-activation. Recently, a considerable amount of evidence has indicated that SREs of skeletal a-actin and a-MHC gene promoters cooperate positively with another muscle-specific element M-CAT which is recognized by transcription enhancer factor-1 (TEF-1) (17, 19, 24) . A combinatorial interaction between both these elements are found necessary for a1-adreneregic, TGFß and stretch induced activation of skeletal a-actin gene expression in cardiac myocytes and slow twitch skeletal muscle fibers (17, 24, 25) . These findings raised a possibility of a mutual cooperation between SRF and TEF-1 proteins.
TEF-1 is a member of a new family of transcription factors that are characterized by a structurally conserved DNA binding domain, TEA/ATTS (26, 27) . Proteins containing TEA domain have been shown to control function in a variety of animals and plant phyla (for review see ref. 26 ).
In humans, at least four different TEF-1 genes have been identified which encode hTEF-1, hTEF-3, hTEF-4, and hTEF-5 isoforms (26) . Homologues of these isoforms have been also isolated from mice (28) and chicks (29) . Members of TEF-1 family have been found to be important for musclespecific expression of several cardiac and smooth muscle genes, and are targets of hypertrophic stimuli (23, 24, (29) (30) (31) . A TEF-1 homologue, scalloped, in Drosophila, has been shown to play an important role in the lineage progression of sensory neuronal development (32) . In mammals, functional TEF-1 is found as early as 2-8 cell stage in the mouse zygote development, and by guest on November 14, 2017 http://www.jbc.org/ Downloaded from
MATERIAL AND METHODS
Over-expression and purification of GST fusion proteins: The GST fusion proteins were expressed in bacteria and purified as described previously (31, 35) . In brief, bacteria harboring plasmids GST-SRF and GST-TEF-1 were grown overnight in LB-ampicillin medium. The next morning, cells were diluted 1:10 with fresh medium, grown to an OD of 0.6-0.75 and induced with 0.1 mM IPTG to direct expression of fusion proteins. After 3-7 hrs of expression of the GST-fusion proteins, cells were harvested and the fusion proteins isolated as follows. Cells were pelleted at 4,000 g at 4 0 C, resuspended in phosphate-buffered saline (PBS) containing protease inhibitors and sonicated for a total elapsed time of 120 seconds. The bacterial lysate was solubilized by the addition of Triton X-100 to a final concentration of 1% and centrifuged at 13,000 g at 4 0 C to remove insoluble material.
Glutathione-agarose beads were added to the soluble supernatant fraction, and the binding of GST fusion proteins was allowed to occur at 4 0 C for 30 minutes. The beads were pelleted in an Eppendorf centrifuge at 4,000 g for 2 minutes and the GST fusion proteins bound to the glutathione-agarose beads were washed thoroughly with PBS containing 0.1% Triton X-100. The integrity of the GSTfusion proteins bound to the beads was analyzed by resolving of proteins on SDS-PAGE and coomassie blue staining, along with known amounts of bovine serum albumin on the same gel to calculate the yield of full-length fusion proteins.
Preparation of nuclear extract and electro-mobility gel shift assay: Nuclear extract was prepared from neonatal rat hearts by the method of Dignam et al. (36) , with slight modifications as described previously (35) . For the electro-mobility gel shift assay (EMSA), double-stranded oligos were 5' endlabeled with T4 polynucleotide kinase (Gibco BRL, Gaithersburg, MD) and [?- After incubation at room temperature for 20 minutes, the reaction mixtures were loaded on 5% native polyacrylamide gels (44:1, acrylamide/bisacrylamide), and electrophoresis was carried out at 150 V in a 0.5 X TBE buffer, in a cold room. For competition and antibody experiments, unlabeled competitor DNAs or the antibody were pre-incubated with nuclear extracts at room temperature for 15-20 minutes in the reaction buffers prior to addition of the labeled DNA probe. The Jurkat T cell nuclear extract, anti-SRF and anti-Flag antibodies used in this study were obtained commercially from The Stratagene Inc, LaJolla, CA and a monoclonal anti-TEF-1 antibody was purchased from
The Transduction Laboratories, Lexington, KY. Sense-strand sequence of double-stranded oligos used in EMSA were:
Affinity-precipitation of SRF with the GST-TEF-1 protein: Five micrograms of GST or GST-TEF-1 bound to glutathione-agarose beads were incubated with 40 µg of neonatal rat heart or Jurkat T cell nuclear extract in 1x DNA-binding buffer for 3 hours at 4 0 C with continuous rocking. Glutathioneagarose beads without GST fusion protein were also incubated with nuclear extract to serve as a negative control. After 3 hours of incubation, beads were pelleted at 14,000 g for 2 minutes, the supernatant was collected and used directly for the mobility gel shift assay. To detect the interaction of SRF with GST-TEF-1 protein, the pelleted beads were washed five times with 1 ml of 1x DNAbinding buffer, suspended in 2x Laemelli's buffer and subjected to subsequent Western blot analysis. and subsequently subjected to Western-blot analysis using either anti-Flag or anti-SRF antibodies.
In order to determine SRF-TEF-1 interaction in cardiac myocytes, the neonatal rat heart 9 nuclear extract (300-500 :g protein) was incubated with 0.5 :g of control mouse or rabbit IgG More than 90% of the cells began to contract spontaneously within 24 hours after plating. Jurkat and Cos1 cells were grown in growth medium containing Dulbecco=s modified Eagle's medium (Gibco, BRL) supplemented with 10% fetal bovine serum in an atmosphere of 5% CO 2 . All culture media contained penicillin (5 mg/ml), streptomycin (5 mg/ml) and neomycin (100 mg/ml).
Primary cultures of cardiac myocytes were transfected after 48 hours in culture with 5 µg of DNA/plate by use of a lipotaxi reagent (Stratagene, Inc, Ca.). Cos1 cells were transcfected by using Calcium phosphate procedure. Typically cells were plated in 100mm plates and after reaching at 50% conflucency they were transfected with 5µg of total DNA. All transfections contained 1 µg of the pCMV-ßgal reference plasmid. The next morning (~18 hrs after transfection) medium was changed and, after an additional 48hrs cells were harvested, cell-lysate prepared, and assayed for luciferase, and ß-galactosidase activities and protein content. The luciferase activity for each construct was corrected for protein content of each extract and normalized to the activity of ß-galactosidase activity in the same cell extract.
Construction of plasmids:
The bacterial expression plasmid pGEX-KG was utilized to direct over-expression of full-length TEF-1 or TEF-1 mutants. Briefly, the full length TEF-1, truncated or point mutated versions of TEF-1 were amplified from pBS-TEF-1 (28) by PCR, digested with Xba1/Xho1, and subcloned into the Xba1/Xho1 sites of the pGEX-KG vector. The GST-TEF-1 expression plasmids were subsequently transformed into HB101 cells for inducible production of the protein.
The skeletal a-actin reporter, -394/+24 Sk-a-actin-luc was constructed by subcloning nucleotides -394
to +24 bp RsaI-HindIII fragment of chicken Sk-a-actin into pXP1 vector. Linker-scanning bglII mutants of the Sk-a-actin promoter have been described before (39) . The p5xSREluc reporter plasmid is directed by an artificial promoter containing five copies of the SRF binding sites (no Ets binding sites) upstream of a minimal TATA box (provided by Dr. J. Solway, University of Chicago).
The 5x M-CAT-luc reporter plasmid containing five copies of cTNT M-CAT-1 element was generated by amplifying five M-CAT-1 sites from an artificial 5x M-CAT promoter/reporter plasmid 
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RESULTS
Physical interaction of TEF-1 with SRF: Our initial goal was to determine whether TEF-1 can physically associate with SRF. To test this possibility we first attempted to deplete the nuclear extract of SRF by affinity precipitation of the protein with GST-TEF-1 beads. The neonatal rat heart nuclear extract or Jurkat T cell nuclear extract, containing high levels of SRF, was incubated with GST-TEF-1 or GST proteins that were immobilized on the glutathione-agarose beads. After removal of GST beads from nuclear extract, the supernatant was analyzed by an EMSA using C(Ar)G oligo as a labeled probe. As shown in figure 1A , the specific SRF/ DNA complex that could be supershifted by SRF antibody, was found to be completely abolished in nuclear-extract samples treated with GST-TEF-1 beads, but not with GST beads alone. These results suggested that a protein physically interacting with TEF-1 segment of the GST fusion protein must be involved in generating the C(Ar)G/protein complex. To find out whether SRF was indeed removed from the nuclear samples, we analyzed the presence of SRF on glutathione-agarose beads by Western blot analysis using an anti-SRF antibody. As shown in figure 1B , SRF was present on GST-TEF-1 beads but not on GST beads alone, thus indicating a direct interaction between SRF and TEF-1 proteins.
These results were confirmed in-vivo by co-immunoprecipitation of SRF with TEF-1 from both Jurkat T cells as well as cardiac myocytes. TEF-1 expression has been shown to be undetectable in lymphocytes (27) . Therefore, in order to see TEF-1/SRF interaction in Jurkat T cells we over- (Fig. 2) . In order to determine interaction of TEF-1 with SRF in cardiac myocytes, cardiac nuclear extract was first pre-cleared with IgG and resulting supernatant was subjected to immunoprecipitataion with either anti-TEF-1 or anti-SRF antibodies conjugated with agarose beads.
Beads were pelleted, washed repeatedly and analyzed by Western-blot analysis. As shown in figure   3 , while an expected band of ~ 54kda of TEF-1 was pull-down by an anti-SRF antibody, two bands of ~67kda and ~53kda of SRF were precipitated by an anti-TEF-1 antibody, whereas, neither protein was precipitated with IgG or agarose beads alone. This lower band of SRF is likely to be an alternatively spliced variant of SRF that has been shown highly expressed in the heart (57) . These results strongly demonstrate an in-vivo TEF-1/SRF association.
Myogenic b-HLH proteins, myogenin and MyoD, have been shown to heterodimerize with E-12 proteins, in order to bind to SRF (15) . Therefore, we were interested to test whether TEF-1 also requires a cofactor to interact with SRF. For this purpose we carried out another protein-protein interaction assay (far-western analysis) in which proteins were resolved by SDS-PAGE, transferred to NC membrane and then hybridized with To define the region of TEF-1 that was necessary for SRF binding, we analyzed several TEF-1 deletion mutants for their ability to interact with in-vitro translated SRF (Fig. 6 ). Each TEF-1 mutant was synthesized as a GST recombinant protein and only those preparations that showed more than fifty percent of the expected size of GST-fusion protein molecules were used for a further study. As shown in figure 6C , GST-TEF-1 mutants in which carboxy terminal region was deleted up to 113 amino acids retained the ability to bind to 35 S-labeled SRF. Likewise, when 113 amino acids N-terminal region of TEF-1 was omitted (GST-TEF 114-430), no binding of SRF was observed.
Another deletion mutation was generated in which N-terminus first 27 amino acids were deleted. The TEA/ATTS DNA-binding domain of TEF-1 is located between 28 to 97 amino acids. It is predicted to consist of either three a-helices or one a-helix and two ß sheet structures (42) . To determine the role of these regions and their potential a-helicity in SRF binding we generated additional TEF-1 mutants, in which amino acids were either deleted or those with high probability of a-helicity were replaced by either proline (P) or glycine (G), having very low probability of a-helix structure (43) . Each mutant was synthesized as GSTBfusion protein in a comparable amount and used to test for their ability to bind to SRF. As shown in figure 7 , the N-terminal 103 amino acids region of TEF-1 was sufficient to bind to in vitro translated 35 S-labeled SRF, and changing two amino acids, Glu (E) and Gln (Q) to G, in the first putative a-helix structure had no effect on their SRF binding ability. In contrast, replacement of two amino acids Ala (A) and Lys (K) to G in the putative 2 nd a-helix, and Gln (Q) and His (H) to P in the 3 rd a-helix completely abolished their ability to bind to SRF. A TEF-1 mutant with deletion of amino acids corresponding to 3 rd putative a-helix structure was also unable to bind to SRF, even when an excess amount of protein was used (Fig.   7C ). These results revealed that amino acids of 2 nd and 3 rd a-helix/ß sheet, but not 1 st a-helix, of the TEA/ATTS domain of TEF-1 mediate interaction with SRF. We also analyzed DNA-binding ability of these TEF-1 mutants using a M-CAT oligo as a labeled probe. As shown in figure 7B , TEF-1 mutant having only 1-103 amino acid region has ability to bind to DNA, albeit several fold lower than the binding ability of the full-length TEF-1. Substitution mutation of two amino acids in the putative 1 st and 3 rd a-helices configuration completely abolished their DNA binding ability (Fig. 7B) . However, replacement of two amino acids in the putative 2 nd "-helix/ß sheet structure resulted in weak but detectable DNA-binding activity, consistent with a previous report (42) . Furthermore, data obtained by the far-western analysis, in which radio-labeled GST-TEF-1 was found to interact with SRF and GST-SRF even when these proteins were denatured and immobilized on the NC membrane indicated that this is a direct and stable interaction between two proteins, and secondary structures of SRF preserved in this assay are sufficient for SRF-TEF-1 association.
Results of this assay also demonstrate that SRF/TEF-1 interaction occurs without need of any cofactor, which is in contrast to requirement of E-12-MyoD heterodimer formation prior to binding to SRF (15) . interacts with SRF either with a composite surface involving portions from both halves of the SRF dimer or with a motif which is exposed only upon dimerization (48) . Our data presented in this study would indicate that dimerization of SRF was not a prerequisite for its binding to TEF-1, as we could observe TEF-1/SRF association even when SRF was denatured and immobilized on the NC membrane. These findings could also explain why SRF binding to TEF-1/M-CAT complex could be seen, while under identical conditions we were unable to detect binding of TEF-1 to SRF/SRE complex. We believe that a single SRF molecule directly binds to TEF-1 to co-occupy the M-CAT site. However, when SRF is bound to SRE as a dimer it is accessible to make tertiary complex with Ets members, as reported before, but not to TEF-1. It is also possible that binding of TEF-1 to SRF reduces its affinity to SRE site and thus both factors could not be seen occupying SRE simultaneously in the conditions applied here. Yet, in vivo they may co occupy SRE site with a lower affinity and that may be important for their coordinated trans-activation function. Recently, a reduced affinity of SRE to SRF has been shown to facilitate ANF gene transcription in cardiac myocytes (20) .
TEF-1 is a prototype member of a large family of transcription factors containing a highly conserved TEA/ATTS DNA-binding domain. Amino acids sequences of the TEA/ATTS domain have been predicted to form three a-helices, or one a-helix and two ß-sheets configuration (26, 42) .
Previously, by mutagenesis, amino acids of helix1 and helix3 have been documented to be essential for protein-DNA contact; however, the role of the 2nd helix amino acids remained unknown (42) .
In the present study, by using deletion and amino-acid substitutions, we have shown that amino complex that has been implicated in controlling the c-fos gene expression in proliferating cells (47) .
Future studies directed towards determining exact amino acids of TEF-1 and SRF involved in their synergistic effect should be able to make a distinction among these possibilities.
In summary, in this study we have demonstrated that SRF and TEF-1 collaborate to activate muscle gene expression and that this cooperativity is mediated by direct protein-protein interaction between MADS and TEA/AATS DNA-binding domains of these two heterologous family of transcription factors. Since MADS and TEA/ATTS domains are highly conserved such an interaction indicates that it would be a common mechanism for these two groups of members to control diversified biological functions, and specificity of this interaction may lie with tissue specific TEF-1 isoforms, other factors binding to these proteins and/or signaling mechanisms that influence their mutual interaction. shown.
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